跳至主要内容
临床试验/CTIS2023-508335-31-00
CTIS2023-508335-31-00进行中(未招募)1 期

ElucidatiNg Immunosuppressant pharmacokinetic variabilities by investigating Gut Microbiota modulations After kidney transplantation - ENIGMA - ENIGMA

niversite Catholique de Louvain0 个研究点目标入组 50 人开始时间: 2023年11月27日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)
性别
All

入选标准

  • (i)diagnosis of chronic renal failure, (ii)planned for a kidney transplantation from a living-donor kidney, (iii)followed at Cliniques universitaires Saint-Luc, (iv)immunosuppressive treatment includes a combination of Tacrolimus (Advagraft) and mycophenolate mofetil (Cellcept), (v)aged between 18 and 75 years old at time of inclusion., (vi)BMI ranging from 18 to 35 kg/m2

排除标准

  • (i)diagnosis of inflammatory bowel disease (IBD), (ii)having undergone or planed for bariatric surgery, (iii)alcohol or drug addiction, (iv)BMI lower than 18 or > than 35 kg/m2, (v)not able to provide informed consent, (vi)pregnancy

研究者

发起方
niversite Catholique de Louvain

相似试验